Pathway-based approach reveals differential sensitivity of glioblastoma to E2F1 inhibition
A. G. Alvarado, K. Tessema, S. D. Muthukrishnan, M. Sober, R. Kawaguchi, A. Bhaduri, V. Swarup, D. A. Nathanson, S. A. Goldman, H. I. Kornblum
This study uses pathway analysis to identify E2F1 as a key driver of glioblastoma proliferation and shows its inhibition sensitizes tumors to radiation.
bioRxiv · Jun 19, 2021Cancer Biology